IL15 and acute myeloid leukemia: Furthermore, treatment of AML harboring the internal tandem duplication in the gene encoding Fms-related tyrosine kinase 3 (FLT3-ITD) with the tyrosine kinase inhibitor, sorafenib, increases IL-15 expression in human AML.